FIELD: medicine.
SUBSTANCE: method involves administering Indinol as alternative means to hormone medication at a dose of 200 mg per day for 2 months following hysteroscopy operation. Then, the dose is reduced to 10 mg per day during the next 2 months. Kipferon is to be concurrently intravaginally administered at a dose of 1 suppository daily during 10 days.
EFFECT: stimulated estradiol production in liver; enhanced effectiveness of local receptor-correcting and immunomodulating action.
2 cl, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT AND METHOD FOR RECURRENT OVARIAN CYST PREVENTION | 2008 |
|
RU2364411C1 |
METHOD OF GESTAGEN-THERAPY OF ENDOMETRIUM HYPERPLASTIC PROCESSES | 2005 |
|
RU2325911C2 |
METHOD OFFUNCTIONAL OVARY CYST TREATMENT | 2008 |
|
RU2357733C1 |
METHOD OF PREOPERATIVE PREPARATION FOR MYOMECTOMY | 2024 |
|
RU2826765C1 |
METHOD OF TREATING BENIGN HYPERPLASTIC ENDOMETRIAL PROCESSES IN PATIENTS WITH METABOLIC SYNDROME | 2010 |
|
RU2438662C1 |
METHOD FOR PREVENTING FOR COMMISSURE PROCESS PROGRESS IN SMALL PELVIS AND OVARIO-MENSTRUAL CYCLE DISORDERS IN WOMEN SUBJECTED TO ENDOSCOPIC OPERATIONS ON OVARY USING ELECTROCOAGULATION | 2003 |
|
RU2238687C1 |
METHOD FOR PREVENTING INFLAMMATORY DISEASES OF SMALL-PELVIS ORGANS AFTER HOSPITAL ABORTION | 2006 |
|
RU2308950C1 |
METHOD FOR MODELING POLYCYSTIC OVARIES AT PREDOMINANCE OF FOLLICULAR CYSTS | 2005 |
|
RU2282249C1 |
METHOD FOR ESTIMATING ENDOMETRIUM CONDITION IN FEMALE GENITALIA NEOPLASM CASES | 2005 |
|
RU2290639C1 |
METHOD FOR TREATING HYPERPLASTIC ENDOMETRIAL PROCESSES COMBINED WITH UTERINE MYOMA | 2006 |
|
RU2317103C1 |
Authors
Dates
2006-04-27—Published
2004-11-04—Filed